Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Major Bleeding Events in Hospitalized COVID-19 Patients: A Retrospective Observational Study.
Poloni A, Casalini G, Pozza G, Giacomelli A, Colaneri M, Carrozzo G, Caloni B, Ciubotariu CL, Zacheo M, Rabbione A, Pieruzzi M, Barone F, Passerini M, Ridolfo AL, Rizzardini G, Gori A, Antinori S. Poloni A, et al. Among authors: antinori s. Medicina (Kaunas). 2024 May 15;60(5):814. doi: 10.3390/medicina60050814. Medicina (Kaunas). 2024. PMID: 38792997 Free PMC article.
Laryngeal Leishmaniasis: A Neglected, Emerging Disease in Northern Italy.
Lazzeroni M, Reato S, Antinori S, Milazzo L, Pignataro L, Cantarella G. Lazzeroni M, et al. Among authors: antinori s. J Voice. 2024 Apr 23:S0892-1997(24)00124-3. doi: 10.1016/j.jvoice.2024.04.006. Online ahead of print. J Voice. 2024. PMID: 38658203 Free article.
Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study.
Colaneri M, Genovese C, Fassio F, Canuti M, Giacomelli A, Ridolfo AL, Asperges E, Albi G, Bruno R, Antinori S, Muscatello A, Mariani B, Canetta C, Blasi F, Bandera A, Gori A. Colaneri M, et al. Among authors: antinori s. Infect Dis Ther. 2024 May;13(5):1147-1157. doi: 10.1007/s40121-024-00967-6. Epub 2024 Apr 21. Infect Dis Ther. 2024. PMID: 38643431 Free PMC article.
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort.
d'Arminio Monforte A, Tavelli A, Di Biagio A, Sarmati L, Marchetti GC, Bai F, Cingolani A, Quiros Roldan E, Mussini C, Lichtner M, Vergori A, Piconi S, Orofino G, Fusco FM, Bandera A, Nozza S, Castagna A, Antinori A; ICONA Foundation Study Group. d'Arminio Monforte A, et al. J Antimicrob Chemother. 2024 Jun 3;79(6):1279-1288. doi: 10.1093/jac/dkae081. J Antimicrob Chemother. 2024. PMID: 38581349
357 results